Prevalence of factor v Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients

Clinical and Applied Thrombosis/Hemostasis

Volumn 18, Issue 3, 2012, Pages 320-323

  Pandey, Sanjay Kumar ^a   Meena, Arvind ^a   Kishor, Kamal ^b   Mishra, R M ^a   Pandey, Sweta ^a   Saxena, Renu ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

^b A P S UNIVERSITY   (India)

Author keywords

factor V Leiden; MTHFR; polymorphism; prothrombin; SCD

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR V LEIDEIN G1691A; PROTHROMBIN; PROTHROMBIN G20210A; UNCLASSIFIED DRUG;

ARTICLE; ASIAN; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANEMIA, SICKLE CELL; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; INDIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION, MISSENSE; POLYMORPHISM, GENETIC; PREVALENCE; PROTHROMBIN; THROMBOPHILIA;

EID: 84860714984     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029611425830     Document Type: Article

References (39)

1. Serjeant GR.. The case for dedicated sickle cell centres. Indian J Hum Genet. 2006 ; 12 (3). 148-151 (Pubitemid 46183414)
2. Steinberg MH, Rosenstock W, Coleman MB, et al. sickle cell anemia. Blood. 1984 ; 63 (6). 1353-1360
3. ßs Gene cluster haplotypes in sickle cell anemia. Clinical and hematologic features. Hematol Oncol Clin North Am. 1991 ; 5 (3). 475-493
4. Rieder RF, Safaya S, Gillette P, et al. Effect of beta-globin gene cluster haplotype on the hematological and clinical features of sickle cell anemia. Am J Hematol. 1991 ; 36 (3). 184-189
5. Figueiredo MS, Kerbauy J, Goncalves MS, et al. Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil. Am J Hematol. 1996 ; 53 (2). 72-76 (Pubitemid 26377691)
6. Lourenço D, Sampaio MU, Kerbauy J, Sampaio CA.. Estimation of plasma kallikrein in sickle-cell anemia, and its relation to the coagulation and fibrinolytic systems. Adv Exp Med Biol. 1989 ; 247B: 553-557
7. Peters M, Plaat BE, ten Cate H, Wolters HJ, Weening RS, Brandjes DP.. Enhanced thrombin generation in children with sickle cell disease. Thromb Haemost. 1994 ; 71 (2). 169-172 (Pubitemid 24047320)
8. Key NS, Slungaard A, Dandelet L, et al. Whole blood tissue factor procoagulant activity is elevated inpatients with sickle cell disease. Blood. 1998 ; 91 (11). 4216-4223 (Pubitemid 28261985)
9. Bayazit AK, Kilinc Y.. Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state. Pediatr Int. 2001 ; 43 (6). 592-596 (Pubitemid 33071122)
10. Setty BN, Rao AK, Stuart MJ.. Thrombophilia in sickle cell disease: the red cell connection. Blood. 2001 ; 98 (12). 3228-3233
11. Hebbel RP.. Thrombogenesis or thrombogenic risk?. J Lab Clin Med. 2001 ; 137 (6). 381-382 (Pubitemid 32473617)
12. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994 ; 369 (6475). 64-67 (Pubitemid 24144355)
13. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM.. A common genetic variation in the 30-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996 ; 88 (10). 3698-3703 (Pubitemid 26383091)
14. Hanson NQ, Aras O, Yang F, Tsai MY.. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem. 2001 ; 47 (4). 661-666 (Pubitemid 32275808)
15. Zimmerman SA, Ware RE.. Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Am J Hematol. 1998 ; 59 (4). 267-272 (Pubitemid 28543614)
16. Andrade FL, Annichino-Bizzacchi JM, Saad ST, Costa FF, Arruda VR.. Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil. Am J Hematol. 1998 ; 59 (1). 46-50 (Pubitemid 28395006)
17. Glueck CJ, Freiberg R, Tracy T, Stroop D, Wang P.. Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin Orthop. 1997 ; 334: 43-56 (Pubitemid 27034874)
18. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991 ; 324 (17). 1149-1155
19. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet. 1995 ; 10 (1). 111-113
20. Margaglione M, Colaizzo D, Cappucci G, et al. Genetic polymorphism of 5,10-MTHFR reductase gene in offspring of patients with coronary infarction. Thromb Haemostasis. 1999 ; 82 (1). 19-23 (Pubitemid 29368767)
21. Kutlar F, Holley L, McKie BC, McKie KM, Woods KF, Kutlar A.. Frequency of a common thermolabile MTHFR (5,10-methylenetetrahydrofolate reductase) mutant among patients with sickle cell disease. Blood. 1997 ; 90 (10 suppl 1). 28b
22. Kutlar F, Tural C, Park D, Markkowitz RB, Woods KF, Kutlar A.. MTHFR (5,10-methylenetetrahydrofolare reductase) 677 C-T mutation as a candidate risk factor for avascular necrosis (AVN) in patients with sickle cell disease. Blood. 1998 ; 82 (10 suppl 1). 695a
23. Fawaz NA, Bashawery L, Al-Sheikh I, Qatari A, Al-Othman SS, Almawi WY.. Factor V-Leiden, Prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia. Am J Hematol. 2004 ; 76 (3). 307-309 (Pubitemid 38828860)
24. Al-Jaouni SK.. Primary thrombophilia in Saudi Arabia. Saudi Med J. 2003 ; 24 (6). 614-616 (Pubitemid 36833552)
25. Belhassen L, Pelle G, Sediame S, et al. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood. 2001 ; 97 (6). 1584-1589 (Pubitemid 32217221)
26. Cumming AM, Olujohungbe A, Keeney S, Singh H, Hay CR, Serjeant GR.. The methylenetetrahydrofolate reductase gene C677T polymorphism in patients with homozygous sickle cell disease and stroke. Br J Haematol. 1999 ; 107 (3). 569-571
27. Balasa VV, Kalinyak KA, Bean JA, Stroop D, Gruppo RA.. Hyperhomocysteinemia is associated with low plasma pyridoxine levels in children with sickle cell disease. J Pediatr Hematol Oncol. 2002 ; 24 (5). 374-379 (Pubitemid 34774008)
28. Romana M, Muralitharan S, Ramasawmy R, Nagel RL, Krishnamoorthy R.. Thrombosis-associated gene variants in sickle cell anemia. Thromb Haemost. 2002 ; 87 (2). 356-358 (Pubitemid 34139887)
29. Koch HG, Nabel P, Junker R, et al. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis. Eur J Pediatr. 1999 ; 158 (suppl 3). S113 - S116
30. Brown K, Luddington R, Baglin T.. Effect of the MTHFRC677T variant on risk of venous thromboembolism: interaction with factor VLeiden and prothrombin (F2G20210A) mutations. Br J Haematol. 1998 ; 103 (1). 42-44 (Pubitemid 28470797)
31. Alhenc-Gelas M, Arnaud E, Nicaud V, et al. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thromb Haemost. 1999 ; 81 (4). 506-510 (Pubitemid 29178931)
32. Kluijtmans LA, den Heijer M, Reitsma PH, Heil SG, Blom HJ, Rosendaal FR.. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb Haemost. 1998 ; 79 (2). 254-258 (Pubitemid 28065865)
33. Margaglione M, D'Andrea G, d'Addedda M, et al. The methylenetetrahydrofolate reductase TT677genotype is associated with venous thrombosis independently ofthe coexistence of the FV Leiden and the prothrombin A20210mutation. Thromb Haemost. 1998 ; 79 (5). 907-911 (Pubitemid 28224721)
34. Salomon O, Steinberg DM, Zivelin A, et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol. 1999 ; 19 (3). 511-518 (Pubitemid 29135149)
35. Morelli VM, Lourenço DM, D'Almeida V, et al. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients. Blood Coagul Fibrinolysis. 2002 ; 13: 271-275 (Pubitemid 35001894)
36. Franco RF, Reitsma PH, Lourenço D, et al. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis. Thromb Haemost. 1999 ; 81 (5). 676-679 (Pubitemid 29216548)
37. Neto FM, Lourenço DM, Noguiti MAE, et al. The clinical impact of MTHFR polymorphisms on the vascular complications of sicklecell disease. Braz Med Biol Res. 2006 ; 39 (10). 1291-1295 (Pubitemid 46357870)
38. Couto FD, Vilas Boas W, Lyra I, et al. AC677T methylenetetrahydrofolate reductase (MTHFR)polymorphisms and G20210A mutation in the prothrombin gene of sickle cell anemia patients from Northeast Brazil. Hemoglobin. 2004 ; 28 (3). 237-241 (Pubitemid 39238146)
39. Franco RF, Araujo AG, Guerreiro JF, Elion J, Zago MA.. Analysis of the 677 C→T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemostasis. 1998 ; 79 (1). 119-121 (Pubitemid 28037069)